Skip to main content
. 2023 Dec 12;12(24):7634. doi: 10.3390/jcm12247634

Figure 1.

Figure 1

A flowchart outlining the Selection Process for Eligible Study population. Clinician-diagnosed MASL/MASH cases from HIRA claims data were chosen for calculating the incidence/prevalence of MASL/MASH, including sex- and age-specific calculations.